11/17
01:19 pm
cnsp
CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript [Seeking Alpha]
Low
Report
CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript [Seeking Alpha]
11/17
09:12 am
cnsp
CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
9/12
10:18 am
cnsp
CNS Pharmaceuticals (NASDAQ:CNSP) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.
Medium
Report
CNS Pharmaceuticals (NASDAQ:CNSP) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.